A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus
© 2024 International Society for Advancement of Cytometry..
The COVID-19 pandemic caused by the SARS-CoV-2 virus has highlighted the need for serological assays that can accurately evaluate the neutralizing efficiency of antibodies produced during infection or induced by vaccines. However, conventional assays often require the manipulation of live viruses on a level-three biosafety (BSL3) facility, which presents practical and safety challenges. Here, we present a novel, alternative assay that measures neutralizing antibodies (NAbs) against SARS-CoV-2 in plasma using flow cytometry. This assay is based on antibody binding to the S protein and has demonstrated precision in both intra- and inter-assay measurements at a dilution of 1:50. The cut-off was determined using Receiver Operating Characteristic (ROC) analysis and the value of 36.01% has shown high sensitivity and specificity in distinguishing between pre-pandemic sera, COVID-19 patients, and vaccinated individuals. The efficiency significantly correlates with the gold standard test, PRNT. Our new assay offers a safe and efficient alternative to conventional assays for evaluating NAbs against SARS-CoV-2.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Cytometry. Part A : the journal of the International Society for Analytical Cytology - (2024) vom: 16. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pscheidt, Veridiane M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 16.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1002/cyto.a.24838 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371131367 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371131367 | ||
| 003 | DE-627 | ||
| 005 | 20240416233734.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240416s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cyto.a.24838 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1377.xml |
| 035 | |a (DE-627)NLM371131367 | ||
| 035 | |a (NLM)38624015 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pscheidt, Veridiane M |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2024 International Society for Advancement of Cytometry. | ||
| 520 | |a The COVID-19 pandemic caused by the SARS-CoV-2 virus has highlighted the need for serological assays that can accurately evaluate the neutralizing efficiency of antibodies produced during infection or induced by vaccines. However, conventional assays often require the manipulation of live viruses on a level-three biosafety (BSL3) facility, which presents practical and safety challenges. Here, we present a novel, alternative assay that measures neutralizing antibodies (NAbs) against SARS-CoV-2 in plasma using flow cytometry. This assay is based on antibody binding to the S protein and has demonstrated precision in both intra- and inter-assay measurements at a dilution of 1:50. The cut-off was determined using Receiver Operating Characteristic (ROC) analysis and the value of 36.01% has shown high sensitivity and specificity in distinguishing between pre-pandemic sera, COVID-19 patients, and vaccinated individuals. The efficiency significantly correlates with the gold standard test, PRNT. Our new assay offers a safe and efficient alternative to conventional assays for evaluating NAbs against SARS-CoV-2 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID‐19 | |
| 650 | 4 | |a PRNT | |
| 650 | 4 | |a S protein | |
| 650 | 4 | |a flow cytometry | |
| 700 | 1 | |a de Souza, Priscila Oliveira |e verfasserin |4 aut | |
| 700 | 1 | |a Fazolo, Tiago |e verfasserin |4 aut | |
| 700 | 1 | |a Modena, José Luiz Proença |e verfasserin |4 aut | |
| 700 | 1 | |a Simeoni, Camila |e verfasserin |4 aut | |
| 700 | 1 | |a Teixeira, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Silva, Natália Brunetti |e verfasserin |4 aut | |
| 700 | 1 | |a Dos Santos, Karina Bispo |e verfasserin |4 aut | |
| 700 | 1 | |a Júnior, Luiz Rodrigues |e verfasserin |4 aut | |
| 700 | 1 | |a Bonorino, Cristina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cytometry. Part A : the journal of the International Society for Analytical Cytology |d 2003 |g (2024) vom: 16. Apr. |w (DE-627)NLM122834658 |x 1552-4930 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:16 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/cyto.a.24838 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 16 |c 04 | ||